Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Primary Care

Sponsor
University of Florida (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01439334
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
0
1
3
19
0

Study Details

Study Description

Brief Summary

The primary purpose of this research is to develop and evaluate the short-term efficacy of an innovative multiple behavior screening, brief intervention and referral to treatment (MB-SBIRT) model using social images and future self-images to simultaneously link and reduce prescription and other co-occurring drug use behaviors among emerging adults in a primary care setting serving a racially and economically diverse community. The long term objective of this research is to cost-effectively reduce prescription and illicit drug abuse, along with alcohol and tobacco consumption, and improve health-related quality of life among high-risk emerging adults often ignored in intervention research and services.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Brief
  • Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Extended Length
  • Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Control
N/A

Detailed Description

Emerging adults are defined as young adults ages 18-25. These young people have the highest levels of prescription, illicit and licit drug consumption of any age group in the nation (Johnston, O'Malley, Bachman, & Schulenberg, 2007). While previous SBIRT models have typically targeted single health risks, such as problem alcohol or cigarette use, the proposed novel multiple behavior SBIRT model uses social and future images and a positive fitness theme to link co-morbid health risk behaviors and problems, and is therefore likely to be viewed by both patients and medical practitioners as appealing and feasible within standard primary care routines.

Objectives

  1. Expanding and modifying existing social and future image screening and brief intervention content from our prior studies to include messages targeting prescription drug abuse and HIV/AIDS risk behaviors, as well as a referral to drug abuse assessment and treatment component;

  2. Translating the modified and expanded multiple behavior SBIRT model content into two versions of the community-friendly computer-based program, i.e., one targeting one health promoting and four risk behaviors vs. another targeting four health promoting and four risk behaviors;

  3. Conducting formative research on the modified content and format to ensure acceptability, quality, feasibility, accessibility, and potential effectiveness among target young adults and health care providers using expert panels, and target audience surveys; and

  4. Conducting a three-group randomized trial pilot test with 3-month follow-up.

A three-group randomized trial pilot test will be conducted, with participating young adult patients randomized to receive either: 1) computer-based MB-SBIRT targeting one health promoting and four risk behaviors, 2) computer based MB-SBIRT targeting four health promoting and four risk behaviors, or 3) primary care as usual. This trial will determine the acceptability, quality, feasibility, and short-term (3-month) effects of the proposed computer delivered MB-SBIRT model.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Multiple Behavior SBIRT Model of Drug Abuse in Primary Care
Study Start Date :
Dec 1, 2009
Anticipated Primary Completion Date :
Jun 1, 2011
Anticipated Study Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Online Program Brief

Online Program Brief

Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Brief
Online prevention program using positive images
Other Names:
  • Online Program Brief
  • Experimental: Online Program Extended Length

    Online Program Extended Length

    Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Extended Length
    Online Program Extended Length
    Other Names:
  • Online Program Extended Length
  • Active Comparator: Control

    Control

    Behavioral: MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Control
    Control
    Other Names:
  • Control
  • Outcome Measures

    Primary Outcome Measures

    1. Change in prescription drug misuse, alcohol, cigarette and marijuana use consumption from baseline to 3 months follow up. [Baseline to 3 months follow up]

    Secondary Outcome Measures

    1. Change in frequency of health promoting behaviors from baseline to 3 months follow up. [Baseline to 3 months follow up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 25 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Understand English

    • 18-25 Year old alcohol-drug using adults

    • Attending the participating family care clinic

    Exclusion Criteria:
    • Can not understand English

    • Not in age range

    • Not attending participating clinic

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Addictive & Health Behaviors Research Institute, University of Florida Jacksonville Florida United States 32256

    Sponsors and Collaborators

    • University of Florida
    • National Institute on Drug Abuse (NIDA)

    Investigators

    • Principal Investigator: Chudley E Werch, PhD, Addictive & Health Behaviors Research Institute, University of Florida

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Florida
    ClinicalTrials.gov Identifier:
    NCT01439334
    Other Study ID Numbers:
    • 2009-U-689
    • R01DA026028
    First Posted:
    Sep 23, 2011
    Last Update Posted:
    Sep 23, 2011
    Last Verified:
    Sep 1, 2011
    Keywords provided by University of Florida
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 23, 2011